Posts

Randi Streisand

Randi Streisand, Ph.D., receives 2020 Richard R. Rubin Award

Randi Streisand

Randi Streisand, Ph.D., is the recipient of the 2020 Richard R. Rubin Award. This national award, sponsored by the American Diabetes Association, recognizes a scientist who has made outstanding, innovative contributions to the study and understanding of the behavioral aspects of diabetes.

Currently, Dr. Streisand is a tenured professor of psychology and pediatrics at The George Washington University School of Medicine and serves as chief of the Division of Psychology & Behavioral Health at Children’s National Hospital. Additionally, she serves as vice-chair for the Institutional Review Board, and provides clinical services for families impacted by diabetes and other health conditions. She is also an active mentor and educator for trainees and early career faculty members regarding research and clinical service.

Throughout her career, Dr. Streisand has received multiple research and training grants, published approximately 100 papers in peer-reviewed journals, and presented at national and international meetings. She has also been recognized for her mentorship and received awards from Children’s National as well as the Society of Pediatric Psychology. Dr. Streisand’s research is funded by the National Institutes of Health (NIH) and focuses on parent-child adjustment to diabetes, and behavioral interventions to promote adjustment, adherence and glycemic control. Her research has included young children through teenagers, and she is currently evaluating the use of a parent coach program to support parents of young children newly diagnosed with type 1 diabetes.

Dr. Streisand has served on several editorial boards for journals, serves as a grant reviewer for NIH, and has served in elected positions for professional organizations. She is also a Certified Diabetes Educator.

Maureen Monaghan

Using text messages and telemedicine to improve diabetes self-management

Maureen Monaghan

Maureen Monaghan, Ph.D., C.D.E., clinical psychologist and certified diabetes educator in the Childhood and Adolescent Diabetes Program at Children’s National Health System, awarded nearly $1.6 million grant from American Diabetes Association.

Adolescents and young adults ages 17-22 with Type 1 diabetes are at high risk for negative health outcomes. If fact, some studies show that less than 20 percent of patients in this population meet targets for glycemic control, and visits to the Emergency Department for acute complications like diabetic ketoacidosis peak around the same age.

The American Diabetes Association (ADA) awarded Maureen Monaghan, Ph.D., C.D.E., clinical psychologist and certified diabetes educator in the Childhood and Adolescent Diabetes Program at Children’s National Health System, nearly $1.6 million to evaluate an innovative behavioral intervention to improve patient-provider communication, teach and help patients maintain self-care and self-advocacy skills and ultimately prepare young adults for transition into adult diabetes care, limiting the negative adverse outcomes that are commonly seen in adulthood.

Dr. Monaghan is the first psychologist funded through the ADA’s Pathway to Stop Diabetes program, which awards six annual research grants designed to spur breakthroughs in fundamental diabetes science, technology, diabetes care and potential cures. Dr. Monaghan received the Accelerator Award, given to diabetes researchers early in their careers, which will assist her in leading a behavioral science project titled, “Improving Health Communication During the Transition from Pediatric to Adult Diabetes Care.”

“Behavior is such a key component in diabetes care, and it’s wonderful that the American Diabetes Association is invested in promoting healthy behaviors,” says Dr. Monaghan. “I’m excited to address psychosocial complications of diabetes and take a closer look at how supporting positive health behavior during adolescence and young adulthood can lead to a reduction in medical complications down the road.”

During the five year study, Dr. Monaghan will recruit patients ages 17-22 and follow their care at Children’s National through their first visit with an adult endocrinologist. Her team will assess participants’ ability to communicate with providers, including their willingness to disclose diabetes-related concerns, share potentially risky behaviors like drinking alcohol and take proactive steps to monitor and regularly review glucose data.

“The period of transition from pediatric to adult diabetes care represents a particularly risky time. Patients are going through major life changes, such as starting new jobs, attending college, moving out of their parents’ homes and ultimately managing care more independently,” says Dr. Monaghan. “Behavioral intervention can be effective at any age, but we are hopeful that we can substantially help youth during this time of transition when they are losing many of their safety nets.”

Study leaders will help participants download glucose device management tools onto their smartphones and explain how to upload information from patients’ diabetes devices into the system. Participants will then learn how to review the data and quickly spot issues for intervention or follow-up with their health care provider.

Patients also will participate in behavioral telemedicine visits from the convenience of their own homes, and receive text messages giving them reminders about self-care and educational information, such as “Going out with your friends tonight? Make sure you check your glucose level before you drive.”

At the study’s conclusion, Dr. Monaghan anticipates seeing improvements in psychosocial indicators, mood and transition readiness, as well as improved diabetes self-management and engagement in adult medicine.